Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Applied Digital Corporation (APLD) vs BioNTech SE - ADR (BNTX) Price & Performance

Applied Digital CorporationTrade
BioNTech SE - ADRTrade

Price performance (Past 24H)

Key statistics

Applied Digital Corporation vs BioNTech SE - ADR — how do they compare? Applied Digital Corporation trades at $32.07 (market cap $8.55B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: BioNTech SE - ADR is far larger — about 2.7× Applied Digital Corporation's market cap, and Applied Digital Corporation is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.

APLDBNTX
Market Cap
$8.55B$23.31B
Sector
TechnologyHealth
52-Week High
$49.65$119.34
52-Week Low
$13.89$83.89
Enterprise Value
$12.06B$6.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Applied Digital Corporation

Applied Digital (APLD) trades at $29.06, down 0.55% on the day, with a bearish technical signal and recent earnings misses. The company reported a net loss of $231.07 million in 2025 despite revenue growth, while analyst consensus remains strongly bullish with a $72.36 price target. Recent news highlights significant AI infrastructure contracts and insider selling activity.

Outlook hinges on execution of its $36 billion AI infrastructure pipeline, but risks include high cash burn, negative margins, and rising debt. The stock offers high growth potential if operational targets are met, yet financial sustainability concerns warrant caution for investors amid volatile sentiment.

BioNTech SE - ADR

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Applied Digital Corporation

Applied Digital provides high-performance computing (HPC) infrastructure and cloud services. It designs and operates data centers tailored for AI, machine learning, and other intensive digital workloads across North America.

Read more on APLD

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX